Mastocytosis Registry from Childhood to Adulthood
Part of Cancer, Immune system & allergy, Skin clinical trials.
This registry collects information from people with mastocytosis (a condition where too many mast cells build up in the skin or organs) who are treated at a specific clinic in Italy. The goal is to better understand how the disease changes over time from childhood to adulthood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cutaneous or systemic mastocytosis.
- You receive care at the Dermatology Unit of Fondazione IRCCS Policlinico San Matteo in Pavia, Italy.
- You are willing to participate in a long-term registry study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a slow-growing type of mast cell disease called indolent systemic mastocytosis. The goal is to better understand the condition and how to manage it, using your genetic information to guide future care.
This study creates a national registry and biobank to collect medical information and biological samples from people with any type of ML, helping research into the condition.
This study follows people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Unit in Pavia. It collects information to better understand the disease and improve care.
This study looks at the health records of people with certain inflammatory skin diseases (such as psoriasis or eczema) in Italy to understand who gets them and what treatments they receive. By joining, you help doctors learn more about how these conditions are managed in real life.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study collects information from people with lung cancer who are treated at a specific hospital in Italy. The goal is to better understand the disease and improve future care.
Hear when a new Cutaneous Mastocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.